Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

Ultrasound facial

Also known as: ultrasonic facial, sonophoresis facial

An ultrasound facial uses sound waves above the range of human hearing, delivered through a skin-contacting probe or spatula. Different systems are offered for cosmetic skin appearance, surface cleansing or application of skincare products.

In plain English — Ultrasound facials use sound waves delivered through a probe or flat spatula. Particular treatments have been studied for skin appearance, redness or use with skincare products, with some encouraging early results. Suitability depends on the exact device, the products applied and the condition of the skin.

Evidence status

Emerging

Early system-specific human evidence. Small human studies report cosmetic or skin-measurement improvements with particular devices and combination treatments. Controlled evidence isolating each device's contribution and sustained clinical benefit remains limited.

What ultrasound facial is, and the types available#

Ultrasound is sound above the range of human hearing. Facial systems transmit this mechanical energy through a handpiece in contact with the skin.[1, 2, 6, 7]i The main cosmetic formats include:

  • Probe-based ultrasound: a smooth treatment head used with a coupling medium; some systems alternate between acoustic frequencies.[1, 2, 6, 7]i
  • Ultrasonic spatulas: blade-shaped handpieces marketed for surface cleansing, exfoliation and product application.[1, 2, 6, 7]i
  • Sonophoresis: the use of ultrasound to assist movement of a substance into or through skin. It describes an application of ultrasound rather than a single device.[2]

Focused-ultrasound tightening has its own entry, HIFU.

Use of ultrasound facial in aesthetic practice#

Cosmetic services centre on skin appearance, surface care and selected topical preparations. Published clinical investigations also include people with acne or rosacea, where assessment and disease management remain part of medical care.[3, 4, 5]i

The exact equipment and its intended use matter to professional scope. The manufacturer’s current instructions govern use of that unit and its compatible preparations. A facial service name alone supplies neither a treatment protocol nor authority to diagnose or manage a skin disease.[4, 6, 8]i

Contraindications and cautions#

Device exclusions. The SkinAct SKU16192 probe manual excludes clients with pacemakers or specified implants, pregnancy and several compromised or vascular skin conditions, including severe rosacea. Its scrubber manual has its own restrictions covering heart disease, infectious disease, metal implants and hypersensitive or vascular skin.[3, 6, 8]i These are product-specific instructions. A rosacea study using another system does not cancel them.[3, 6, 8]i

Topical preparations. Known allergy excludes the implicated gel or skincare product. Sensitivity to a botanical, fragrance or acid-containing preparation remains relevant when a device is used to apply it.[4, 6, 8]i

Current skin condition. Active inflammation, damaged skin or an uncertain facial eruption changes suitability. Assessment includes recent procedures and current treatment; medical review may be needed before another cosmetic intervention.[9, 10]i

Clinical uses and the evidence behind them#

Cosmetic skin appearance

An uncontrolled multicentre study of 39 adults aged 30–63 reported improved facial wrinkle, pore and turgor ratings after LDM-MED treatment. Assessment was approximately one week after an eight-to-12-treatment course. A co-author was managing partner of Wellcomet, the device manufacturer, and reportedly took no part in treatment or evaluation; a separate funding statement was not located.[5]

Facial redness and water loss

A SONOSTYLER study enrolled 28 Asian adults and followed 26 completers aged 23–55: 15 had rosacea and 11 acne. Overall clinical redness scores and transepidermal water loss improved after a four-week cheek-treatment course, with follow-up to week six. Instrumental redness measurements were available for 13 participants. There was no control group. WEYERGANS, the device manufacturer, funded the study; the authors separately declared no conflicts.[3]

Acne-related outcomes with topical preparations

A randomised trial in 60 women aged 19–23 compared facial ultrasound and gel with ultrasound plus a multicomponent preparation containing green tea, bamboo extract and lactic acid. With 30 women per arm, acne severity and several regional sebum measurements favoured the combination during a five-week course and two-week follow-up. The authors reported no external funding or conflicts.[4] This is evidence about that combined intervention in young women; established acne care remains the clinical starting point.[9, 10]i

Selecting ultrasound facial#

Selection begins with the aim: surface cleansing, a cosmetic appearance concern or application of a particular preparation. The device model, handpiece, intended use and topical ingredients should correspond to that aim.[4, 6, 8]i

Relevant client factors include current skin condition, implanted devices, medical and reproductive history, allergy history and recent treatment. The manufacturer’s instructions determine compatible products and operating requirements; Skinipedia does not provide settings, treatment courses or aftercare regimens.[4, 6, 8]i

Adverse effects and their management#

Reported study effects. Transient redness occurred in the 39-person cosmetic series. The 26-completer redness study reported no severe adverse events, pain, burning or worsening redness, while the 60-woman sonophoresis trial reported no irritation or redness. These selected samples cannot establish a rare-event rate.[3, 4, 5]i

Mechanical or thermal injury. The scrubber manufacturer warns about burns from prolonged stationary contact and scratches from a damaged blade.[8]i Persistent pain, burning, blistering or other visible injury warrants stopping the cosmetic treatment and appropriate assessment; continuing exposure is not a response to an adverse reaction.[8]i

Preparation reactions. A reaction may involve the applied gel or skincare as well as the equipment. The full treatment record, including products and device used, is relevant to assessment.[4, 6, 8]i

Referral and scope boundaries#

Uncertain diagnosis, nodulocystic acne, scarring, persistent pigmentary change or significant psychological distress belongs on a medical pathway. Cosmetic ultrasound is not a substitute for that assessment.[9, 10]i

Rosacea requires management matched to its clinical features. Eye pain, visual changes or other concerning ocular involvement requires clinical assessment; the presence of a study involving facial redness does not establish suitability for treating the eyes.[9, 10]i

Mechanism of action#

A transducer converts electrical energy into mechanical sound waves. A coupling medium reduces the air gap between the handpiece and skin, allowing sound transmission. Tissue effects can involve heating or mechanical interactions, according to the equipment and exposure.[1]

Sonophoresis research describes acoustic cavitation and altered skin permeability. Cavitation refers to the behaviour of bubbles under an acoustic field; the relevant location and contribution vary with ultrasound conditions. These mechanisms provide the scientific basis for ultrasound-assisted delivery.[2]

Commonly misstated claims#

Focused-ultrasound tightening

Claim heard:“An ultrasound facial gives the same tightening as HIFU.”

Literature finding: Focused ultrasound directs energy to a target, whereas the facial probe and spatula services described here have different designs and intended effects. Sharing a sound-based technology does not make their clinical evidence interchangeable.[1, 3, 6, 7]i

Supported statement: Tightening claims require evidence for the actual device and its intended tissue effect.[1, 3, 6, 7]i

Sonophoresis and topical-product effects

Claim heard:“The sonophoresis trial proves ultrasound makes that serum work better.”

Literature finding: Both groups in the 60-woman trial received ultrasound. The comparison added a multicomponent topical preparation in one group; it did not compare identical skincare with and without ultrasound or directly measure product penetration.[4]i

Supported statement: The tested combination improved acne-related outcomes compared with ultrasound and gel alone; the added contribution of ultrasound to that preparation remains unresolved.[4]i

Water-loss and hydration measurements

Claim heard:“The redness study measured a percentage increase in hydration.”

Literature finding:The study measured water leaving the skin—TEWL—not direct stratum-corneum water content. Its TEWL values also differ between the text and table, so a precise percentage should not be lifted from the report.[3]i

Supported statement: The study reported an overall reduction in measured water loss, alongside clinical redness improvement.[3]i

Areas of remaining uncertainty#

  • Durability and maintenance: These studies assessed outcomes close to treatment completion; they do not establish a maintenance strategy, so no lasting benefit or repeat-treatment schedule can be promised from them.[5]
  • Responder selection:The studies cover different age groups and skin concerns without a validated selection rule; expected benefit should therefore be framed for the actual client’s concern rather than a universal skin-type claim.[3, 4, 5]i
  • Patient-important outcomes: Future work could establish which measurement changes translate into sustained comfort or meaningful cosmetic improvement, helping clinicians and clients judge whether a treatment is worthwhile.[3]

Frequently asked questions#

What does sonophoresis mean?

Ultrasound-assisted delivery into or through skin. The equipment and applied preparation both form part of the intervention.[2]

Can the same gel be used with any machine?

Compatibility is set by the instructions for the exact device and preparation. A product being suitable for ordinary topical use does not establish compatibility with every ultrasound unit.[3, 6, 8]i

Can a client with rosacea have an ultrasound facial?

Suitability depends on the diagnosis, current skin condition and exact unit. Some manufacturers exclude vascular or rosacea-prone skin, and those exclusions still apply.[3, 6, 8]i

Which page covers focused-ultrasound lifting?

HIFU covers focused-ultrasound tightening and its separate evidence and safety considerations.[1, 3, 6, 7]i

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. National Institute of Biomedical Imaging and Bioengineering. Ultrasound. Updated December 2023.Tier 4Supports: Original public science overview; acoustic waves, transducers, coupling gel, diagnostic versus therapeutic uses, focused ultrasound and tissue heating/mechanical effects. Not a cosmetic facial efficacy guideline.Funding / interest: US National Institutes of Health public educational material; no commercial sponsorship identified.
  2. Polat BE, Hart D, Langer R, Blankschtein D. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release. 2011;152(3):330–348. doi:10.1016/j.jconrel.2011.01.006. PMID:21238514.Tier 4Supports: Original abstract retrieved; sonophoresis definition and frequency-dependent cavitation/permeability mechanisms. Full article inaccessible through attempted routes; no product-specific delivery percentage inferred.Funding / interest: Indexed NIH/NIBIB grant support is visible, but complete funding and conflict declarations were not available in the retrieved abstract; no assumption of independence.
  3. Kim YJ, Moon IJ, Lee HW, Won CH, Chang SE, Lee MW, Choi JH, Lee WJ. The Efficacy and Safety of Dual-Frequency Ultrasound for Improving Skin Hydration and Erythema in Patients with Rosacea and Acne. J Clin Med. 2021;10(4):834. doi:10.3390/jcm10040834. PMID:33670631.Tier 3Supports: Full original article; uncontrolled cheek study, 28 enrolled/26 completed, Asian adults aged 23–55, 15 rosacea/11 acne, four-week treatment with assessment to week six. Instrumental erythema subset n=13. Conflicting TEWL baseline values/captions preclude importing an exact numerical effect; no CIs reported.Funding / interest: Funded by WEYERGANS, manufacturer of the SONOSTYLER device used. Authors separately declared no conflicts of interest.
  4. Chilicka K, Rogowska AM, Rusztowicz M, Szyguła R, Yanakieva A, Asanova B, Wilczyński S. The Effects of Green Tea (Camellia sinensis), Bamboo Extract (Bambusa vulgaris) and Lactic Acid on Sebum Production in Young Women with Acne Vulgaris Using Sonophoresis Treatment. Healthcare. 2022;10(4):684. doi:10.3390/healthcare10040684. PMID:35455861.Tier 2Supports: Full original randomised trial; 60 women aged 19–23, 30 per arm, five-week facial course and two-week post-course follow-up. Both arms ultrasound/gel; one adds a multicomponent botanical/lactic-acid ampoule. Acne and regional sebum outcomes; no CIs supplied.Funding / interest: Authors reported no external funding and no conflicts of interest.
  5. Meyer-Rogge D, Rösken F, Holzschuh P, D’hont B, Kruglikov I. Facial Skin Rejuvenation with High Frequency Ultrasound: Multicentre Study of Dual-Frequency Ultrasound. J Cosmet Dermatol Sci Appl. 2012;2:68–73. doi:10.4236/jcdsa.2012.22016.Tier 3Supports: Full original article; uncontrolled multicentre full-face series, 39 adults aged 30–63, eight to 12 treatments, assessment approximately one week after completion. Graded wrinkles, pores and turgor; transient erythema reported. Two preliminary split-face examples are not controls for the main cohort. No CIs reported.Funding / interest: Kruglikov disclosed being managing partner of Wellcomet, manufacturer of LDM-MED; authors stated he did not treat or evaluate participants. Separate funding statement not located.
  6. SkinAct. Ultrasonic and Cold/Hot Therapy Skin Care Machine, SKU16192: user manual. Undated.Tier 4Supports: Original eight-page manual; probe identity, coupling and product-specific exclusions, including pacemakers/implants, pregnancy, compromised skin and severe rosacea/vascular conditions. Marketing mechanisms are not independent clinical evidence.Funding / interest: Manufacturer's commercial equipment instructions.
  7. SkinAct. Skin Scrubber Facial Skin Care Unit, SKU25362: product description. Undated. Accessed 16 September 2026.Tier 4Supports: Original manufacturer description of a facial ultrasonic spatula marketed for cleansing, exfoliation and product application. Used for intended role, not proof of efficacy or absence of irritation.Funding / interest: Manufacturer/supplier commercial product page.
  8. SkinAct. Skin Scrubber Facial Skin Care Unit, SKU25362: user manual. Undated.Tier 4Supports: Original four-page manual; specified health/skin exclusions, burn risk from prolonged stationary contact and scratching risk from a damaged blade. Attachment directory number differs from the product SKU.Funding / interest: Manufacturer's commercial equipment instructions.
  9. National Institute for Health and Care Excellence. Acne vulgaris: management. NG198. Updated 3 August 2026. Recommendations 1.4.Tier 1Supports: Original current recommendations; referral for diagnostic uncertainty, nodulocystic acne, scarring, persistent pigmentary changes and psychological distress. Not a device-specific operator-permission source.Funding / interest: Publicly developed NICE guideline with committee interests managed through NICE's process.
  10. Hampton PJ, Berth-Jones J, Duarte Williamson CE, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol. 2021;185(4):725–735. doi:10.1111/bjd.20485.Tier 1Supports: Original complete guideline; individualised rosacea management, supportive skincare and ocular referral. No inference that omission of a device proves inefficacy.Funding / interest: No funding reported. Author disclosures include PJH research or educational/travel relationships with LEO, Janssen, UCB and Eli Lilly; CEDW speaking for AbbVie, Galderma and Janssen; TAL advisory work for Galderma, La Roche-Posay and Novartis and Novartis speaking; DS Galderma conference travel. JBJ previously ran a rosacea clinical-trial unit.